BHIVA statements on third vaccine doses for people living with HIV
17 September 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
2021
HIV increases risk of severe COVID-19 in largest US study
17 September 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
SARS-CoV-2 variants and immunosuppression
17 September 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
UK vaccine programme saved 100,000 lives
17 September 2021. Related: COVID-19: vaccine research, COVID-19.
Large US registry confirms safety of COVID-19 vaccines during pregnancy
17 September 2021. Related: COVID-19: vaccine research, COVID-19.
US FDA grants full approval to Pfizer vaccine
17 September 2021. Related: COVID-19: vaccine research, COVID-19.
Immune responses against Delta variant in people vaccinated in the UK
17 September 2021. Related: COVID-19: vaccine research, COVID-19.
Neutralising antibody levels from COVID vaccines correlate negatively with age
17 September 2021. Related: COVID-19: vaccine research, COVID-19.
Evolution of neutralising antibody responses to natural infection and after vaccination
17 September 2021. Related: COVID-19: vaccine research, COVID-19.
Outbreak of 469 symptomatic Delta cases in fully vaccinated adults during Bear Week
17 September 2021. Related: COVID-19: transmission & prevention, COVID-19.
Job vacancies: Medical writer
17 September 2021. Related: Job vacancies.
HTB: no. 9 – plus HIV and COVID-19 (17 September 2021)
17 September 2021. Related: PDFs.
HTB: no. 8 – plus HIV and COVID-19 (1 August 2021)
1 August 2021. Related: Editorial.
11th IAS Conference on HIV Science (IAS 2021)
1 August 2021. Related: Conference reports.
IAS 2021: lenacapavir studies show impressive results in naive, extensive drug resistance and potential as PrEP
1 August 2021. Related: Conference reports, Antiretrovirals.
IAS 2021: HIV pipeline drugs: CAB/RPV LA, fostemsavir, paediatric dolutegravir, lenacapavir, islatravir, MK-8507 and albuvirtide
1 August 2021. Related: Conference reports, Antiretrovirals.
IAS 2021: Proving efficacy of next generation PrEP: counterfactual controls in lenacapavir and islatravir studies
1 August 2021. Related: Conference reports, HIV prevention and transmission, Research studies.
IAS 2021: WHO report links HIV to 30% increased mortality from COVID-19: based on South African data
1 August 2021. Related: Conference reports, COVID-19: HIV and COVID-19 coinfection, COVID-19.
IAS 2021: New demands for better transgender heath care: No data no more
1 August 2021. Related: Conference reports, HIV prevention and transmission.
13th International Workshop on HIV Paediatrics 2021
1 August 2021. Related: Conference reports, Paediatric care.
Dolutegravir superior to standard-of-care in young children: results from the ODYSSEY trial
1 August 2021. Related: Conference reports, Paediatric care.
UK Biobank study finds no link between CMV and cardiovascular disease: HIV not included
1 August 2021. Related: Coinfections and complications.
Phase 1 HIV mosaic vaccine study launched at Oxford university
1 August 2021. Related: HIV prevention and transmission, Vaccines and microbicides.
Ending the HIV epidemic (EHE) in the US
1 August 2021. Related: On the web.
Antibody responses to Pfizer vaccine in HIV positive people with high CD4 counts
1 August 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
Third dose of mRNA vaccine improves antibody responses in kidney transplant recipients
1 August 2021. Related: COVID-19: vaccine research, COVID-19.
US CDC recommends third vaccine dose in some groups
1 August 2021. Related: COVID-19: vaccine research, COVID-19.
Pfizer plans for third dose: questions over population need?
1 August 2021. Related: COVID-19: vaccine research, COVID-19.
Efficacy of Oxford/AZ and Pfizer vaccines against Delta variant in the UK
1 August 2021. Related: COVID-19: vaccine research, COVID-19.
Results from Novavax phase 3 study in the UK
1 August 2021. Related: COVID-19: vaccine research, COVID-19.
WHO approves Chinese vaccines for emergency use
1 August 2021. Related: COVID-19: vaccine research, COVID-19.
Selected other vaccine studies
1 August 2021. Related: COVID-19: vaccine research, COVID-19.
Efficacy of Chinese CoronaVac vaccine in Chile national programme
1 August 2021. Related: COVID-19: vaccine research, COVID-19.
NHS supports selected use of inhaled budesonide for COVID-19 in people at risk of severe events
1 August 2021. Related: COVID-19: investigational drugs, COVID-19.
Reviews of ivermectin for COVID-19: no evidence of benefit from RCTs
1 August 2021. Related: COVID-19: investigational drugs, COVID-19.
RCT shows no impact of azithromycin in reducing symptoms of mild COVID-19
1 August 2021. Related: COVID-19: investigational drugs, COVID-19.
Variation in ACE2 levels are not related to outcomes from COVID-19
1 August 2021. Related: COVID-19: pathogenesis, COVID-19.
HTB: no. 8 – plus HIV and COVID-19 (1 August 2021)
1 August 2021. Related: PDFs.
HTB: no. 7 – plus HIV and COVID-19 (1 July 2021)
1 July 2021. Related: Editorial.
5th Joint BHIVA/BASHH Conference 2021
1 July 2021. Related: Conference reports.
Few vertical HIV transmissions in the UK but contributing factors remain associated with inequality
1 July 2021. Related: Conference reports, Pregnancy.
Lenacapavir submitted to FDA as long-acting treatment for MDR HIV
1 July 2021. Related: Antiretrovirals.
US HIV treatment guidelines updated (June 2021)
1 July 2021. Related: Guidelines.
Predicting likelihood of post treatment control in HIV cure-related studies that interrupt ART
1 July 2021. Related: Cure-related research.
London HIV study of responses to COVID-19 vaccines and natural infection (SCAPE)
1 July 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19: research studies, COVID-19.
mRNA vaccine fails to produce antibody response in late-stage HIV: low CD4 count and high viral load
1 July 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
Special report on background incidence of adverse events in vaccine studies
1 July 2021. Related: COVID-19: vaccine research, COVID-19.
Third vaccine dose increases immune response to 68% in French transplant recipients
1 July 2021. Related: COVID-19: vaccine research, COVID-19.
Third COVID-19 vaccine dose in US cohort of people on immune-suppressing treatment: safety and ethical issues
1 July 2021. Related: COVID-19: vaccine research, COVID-19: treatment access, COVID-19.
Plans for universal third vaccine dose for UK adults from September
1 July 2021. Related: COVID-19: vaccine research, COVID-19.
COVID-19 vaccines increase sperm quality: potential to help uptake
1 July 2021. Related: COVID-19: vaccine research, COVID-19.
Research approach to rapidly review candidate treatments for COVID-19: nine studies using ACTIV protocol
1 July 2021. Related: COVID-19: investigational drugs, COVID-19: research studies, COVID-19.
US likely to have had SARS cases in December 2020
1 July 2021. Related: COVID-19: transmission & prevention.
COVID-19 treatment: tofacitinib, REGN bNAbs, convalescent plasma
1 July 2021. Related: COVID-19: investigational drugs, COVID-19.
Virology Education: monthly forums on COVID-19
1 July 2021. Related: COVID-19: on the web, COVID-19.
COVID-19 timeline: global events from the last 18 months
1 July 2021. Related: COVID-19: on the web, COVID-19.
COVIDsalon
1 July 2021. Related: COVID-19: on the web, COVID-19.
HTB: no. 7 – plus HIV and COVID-19 (1 July 2021)
1 July 2021. Related: PDFs.
HTB: no. 6 – plus HIV and COVID-19 (1 June 2021)
1 June 2021. Related: Editorial.
5th joint BHIVA/BASHH conference 2021
1 June 2021. Related: Conference reports.
Weight changes on ART and how to lose weight successfully
1 June 2021. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications, Nutrition.
Selected presentations at BHIVA: COVID-19, PrEP in the UK, community involvement and more…
1 June 2021. Related: Conference reports, COVID-19: transmission & prevention, COVID-19.
28th Conference on Retroviruses and Opportunistic Infections (CROI 2021) virtual
1 June 2021. Related: Conference reports.
No differences in outcomes among women with and without HIV with high-risk pregnancies and COVID-19
1 June 2021. Related: Conference reports, Pregnancy, COVID-19: pathogenesis, COVID-19.
Dolutegravir-based regimens safe and effective in pregnancy and postpartum
1 June 2021. Related: Conference reports, Pregnancy.